In the third quarter and nine months ended March 31, 2026, News Corporation reported higher sales and revenue year on year, but lower net income and earnings per share overall, even as earnings from continuing operations per share edged up to US$0.16 for the quarter and US$0.70 for the nine months.
The company also continued executing on its up to US$1.00 billion share repurchase program, signaling an ongoing focus on capital returns despite the mixed earnings picture.
Next, we’ll examine...
In the first quarter of 2026, National Presto Industries, Inc. reported sales of US$118.65 million, up from US$103.64 million a year earlier, while net income declined to US$6.63 million and basic earnings per share from continuing operations fell to US$0.93 from US$1.07.
This combination of higher revenue but lower profitability highlights rising costs or margin pressure as a key theme in the company’s recent performance.
Against this backdrop of revenue growth but softer earnings, we’ll...
Why IDEX stock is drawing attention now
IDEX (IEX) is drawing fresh attention after recent trading left the stock around $205.15, with performance mixed over the past week, month, and past 3 months, while the year-to-date return remains positive.
See our latest analysis for IDEX.
Recent trading has been choppy, with the 7 day share price return down 4.07% and the 90 day share price return down 1.83%, while the year to date share price return of 14.57% and 1 year total shareholder return of...
Baidu (NasdaqGS:BIDU) opened Q1 2026 with revenue of C¥32.1b and basic EPS of C¥10.13, compared with C¥34.1b of revenue and basic EPS of C¥13.27 in Q4 2024. On a trailing 12 month basis, EPS stood at C¥1.15. Over recent quarters the company has seen revenue move from C¥32.5b and EPS of C¥22.44 in Q1 2025, through a loss-making Q3 2025, before settling at revenue of C¥32.1b and EPS of C¥10.13 this quarter. This sets up an earnings story where a 0.3% trailing net margin and a large one-off loss...
Addus HomeCare is leaning into its acquisition playbook in personal care services, with management signaling interest in larger deals supported by a solid balance sheet.
The company reports that recent federal moratoriums on certain home health licenses have had limited impact, since its core growth focus is personal care, which is outside the new restrictions.
Operations in Illinois, Texas, and New Mexico are showing improving personal care service trends, aided by technology investments...
Investors may be wondering whether Viavi Solutions at US$49.28 is still priced attractively after a big run, or if the easy money has already been made.
The stock has pulled back about 7.7% over the last week. However, it is up 11.7% over the last month, 171.5% year to date and 432.2% over the past year.
Recent coverage has focused on Viavi Solutions as a high momentum tech stock, with investors reacting to its strong share price move over the last 12 months. Commentary has also highlighted...
Marcus & Millichap (NYSE:MMI) has released new national research reports on the U.S. single tenant net lease retail sector.
The reports highlight strength in STNL retail fundamentals and a pickup in transaction activity.
The findings focus on financing conditions and market activity within a key business line for the company.
For investors following Marcus & Millichap, the new STNL research adds another piece to the picture around the company’s retail-focused brokerage and advisory work...
In recent months WesBanco has completed the integration of Premier Financial and continued its push into higher-growth markets such as Northern Virginia and Knoxville, reshaping its regional footprint.
This expansion is reshaping the bank’s mix of loans and deposits, with investors closely watching how it balances growth opportunities against commercial real estate and cost risks.
Next, we’ll examine how WesBanco’s expansion into markets like Northern Virginia and Knoxville may influence...
AMETEK (NYSE:AME) has appointed former Hexcel CEO Nick L. Stanage to its Board of Directors.
The company is in discussions to acquire a portfolio of instrumentation businesses from Indicor, LLC.
Both developments relate to AMETEK's focus on expanding its presence in advanced instrumentation and industrial technology markets.
AMETEK operates as a global manufacturer of electronic instruments and electromechanical devices, serving industrial and aerospace customers, among others. The...
Earlier in May 2026, GigaCloud Technology Inc. reported first-quarter 2026 results showing revenue of US$359.49 million and net income of US$38.12 million, issued second-quarter revenue guidance of US$365 million to US$390 million, completed a US$42.6 million share repurchase program, and outlined its outlook ahead of a conference appearance in New York.
The results highlighted continued expansion of GigaCloud’s global B2B marketplace, including strong third-party seller activity and...
Wellington Management affiliates have disclosed a new passive 5.06% stake in Atlanticus Holdings (NasdaqGS:ATLC) via a Schedule 13G filing.
The filing signals fresh institutional attention on the company’s credit focused business model.
The new position has not been covered in recent commentary on Atlanticus and is separate from earnings or valuation discussions.
Atlanticus Holdings, trading at $78.1, has drawn renewed interest after the Wellington position. The stock has shown a 53.9%...
Advertising technology has become one of the most interesting corners of the market. As businesses continue shifting budgets toward digital channels, advertisers are looking for tools that can improve return on ad spend, automate campaign decisions, and turn marketing dollars into measurable results.
Recent share performance and business context
Edgewise Therapeutics (EWTX) has drawn investor attention after a mixed stretch in the stock, with the price down about 9% over the past month but up roughly 4% over the past 3 months.
Over longer periods, the stock shows a year to date gain of about 32% and a 1 year total return a little above 111%, alongside a 3 year total return a little above 224%, on a market value near US$3.4b.
The company focuses on therapies for muscle disorders, with lead...
